Sensei biotherapeutics presents new preclinical data reinforcing sns-101 pharmacokinetic profile, safety characteristics and mechanism of action at the seventh cri-enci-aacr international cancer immunotherapy conference

- new data from multi-dose glp toxicology study of sns-101 in cynomolgus monkeys further support exceptional pk and safety profile -

SNSE Ratings Summary

SNSE Quant Ranking